Similarly, in the Lira-1 trail the use of a GLP-1 analogue (Liraglutide 1.8 mg once a day) was associated with 6.8 kg weight loss compared to placebo in individuals with T1DM who were overweight [26]. This evidence concerns the gene GCG and type 1 diabetes mellitus.